Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 8/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 8/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.34 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21122927 | 0.86 | P2RY12 (0.35) | TDP1ATMNPSR1POLBMAPT | |
| SCHEMBL12463168 | 0.86 | P2RY12 (0.35) | TDP1ATMNPSR1POLBMAPT | |
| SCHEMBL12462486 | 0.86 | FOLH1 (0.45) | — | |
| SCHEMBL12374469 | 0.82 | USP2 (0.40) | — | |
| SCHEMBL23912446 | 0.82 | SSTR2 (0.39) | TDP1ATMSSTR2NPSR1POLB | |
| SCHEMBL21065264 | 0.80 | TDP1 (0.43) | TDP1ATMNPSR1POLBKMT2A | |
| SCHEMBL21065266 | 0.80 | TDP1 (0.43) | TDP1ATMNPSR1POLBKMT2A | |
| SCHEMBL522870 | 0.73 | PAOX (0.39) | — | |
| SCHEMBL15978635 | 0.73 | PAOX (0.39) | — | |
| SCHEMBL22590659 | 0.73 | KDM4E (0.38) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2021-10-12 | — | — | US | disclosed |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2020-10-27 | — | — | US | disclosed |
| EP-2521530-B1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | OREAL (FR) | 2019-06-26 | — | — | EP | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| WO-2011080494-A2 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | KRT18, KIT, TYR | TDP1 4164/4885ATM 1273/4885SSTR2 670/4885 |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | TDP1 4164/4885ATM 1273/4885SSTR2 670/4885 |
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | TDP1 4164/4885ATM 1273/4885SSTR2 670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.